Stem cell therapy has an unparalleled potential to treat blood cancers, cardiovascular diseases and neurodegenerative conditions, among others. However, stem cell therapeutics must overcome multiple requirements before reaching clinical trials, including large animal safety and efficacy studies. In cardiovascular diseases swine models are the most widely adopted due to its great translational potential to humans. In this chapter, we will describe several protocols to induce iPSC dedifferentiation in swine fibroblasts, as well as conditioning treatments that may help in the reprogramming process.
Keywords: Episomal nucleofection reprogramming; Porcine iPSC; RNA reprogramming; Retroviral reprogramming; Sendai virus reprogramming.
© 2021. Springer Science+Business Media, LLC.